Pre-made Faralimomab benchmark antibody (Whole mAb, anti-IFNA1 therapeutic antibody, Anti-IFL/IFN/IFN-ALPHA/IFN-alphaD/IFNA13/leIF D Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-INN-849

Anti-IFNA1 therapeutic antibody (Pre-made Faralimomab biosimilar, Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Faralimomab is a mouse monoclonal antibody and an immunomodulator.[1][2]

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-INN-849-1mg 1mg 3090
GMP-Bios-INN-849-10mg 10mg Inquiry
GMP-Bios-INN-849-100mg 100mg Inquiry
GMP-Bios-INN-849-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Faralimomab Biosimilar, Whole Mab, Anti-Ifna1 Antibody: Anti-IFL/IFN/IFN-ALPHA/IFN-alphaD/IFNA13/leIF D therapeutic antibody
INN Name Faralimomab
TargetIFNA1
FormatWhole mAb
DerivationMus musculus
Species Reactivityhuman
CH1 IsotypeIgG1 - nd
VD LCIgG1 - nd
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
CompaniesMedarex (Princeton NJ USA)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech0